Production (Stage)
PMV Pharmaceuticals, Inc.
PMVP
$0.97
$0.022.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.18% | -45.98% | -15.54% | 93.04% | 20.17% |
| Total Depreciation and Amortization | -89.78% | -89.14% | 3.63% | 0.81% | 111.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -25.61% | 383.57% | -39.94% | -38.56% | -57.84% |
| Change in Net Operating Assets | 29.39% | -37.39% | 254.84% | -198.94% | -219.78% |
| Cash from Operations | -12.86% | -37.87% | -7.54% | 87.61% | -7.81% |
| Capital Expenditure | 99.33% | 71.57% | 97.73% | 99.29% | -280.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.32% | 416.94% | 150.87% | 103.67% | -46.27% |
| Cash from Investing | 9.74% | 399.23% | 150.89% | 103.63% | -47.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -40.28% | -100.00% | -93.38% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -40.28% | -100.00% | -93.38% | -- |
| Foreign Exchange rate Adjustments | 120.59% | -132.35% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.20% | 38.99% | 101.76% | 101.17% | -71.29% |